Posts in category Healthcare


Maxim Analyst Comments on Cytori Therapeutics Inc Following Azaya Acquisition

Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Cytori Therapeutics Inc (NASDAQ:CYTX) …

Read more

William Blair Heads to Sidelines on CoLucid Pharmaceuticals Inc (CLCD)

William Blair analyst Tim Lugo is downgrading CoLucid (NASDAQ:CLCD) following the announcement of the firm’s …

Read more

BTIG Positive on Synergy Pharmaceuticals Inc (SGYP) Ahead of Upcoming FDA Decision

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) investors are eagerly awaiting the FDA’s decision on plecanatide’s (for the treatment …

Read more

Healthcare Sell-Side Analysts Head to Sidelines on CoLucid Pharmaceuticals Inc (CLCD) and Alcobra Ltd (ADHD)

CoLucid Pharmaceuticals Inc CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) shares are on the run today after the …

Read more

Cantor Cheers As Jazz Pharmaceuticals plc Shares Rise 9%

Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) stock is on a 9% rise after receiving …

Read more

Cowen Highlights 4 Biotech Stocks Ahead of Earnings: Gilead Sciences, Inc. (GILD), Merrimack Pharmaceuticals Inc (MACK), ACADIA Pharmaceuticals Inc. (ACAD), Exelixis, Inc. (EXEL)

As earnings season rolls to the foreground and key biotech players like Gilead Sciences, Inc. (NASDAQ:GILD), …

Read more

Biotech Insights: Alcobra Ltd (ADHD), Biogen Inc (BIIB), Juno Therapeutics Inc (JUNO)

Alcobra Ltd  Alcobra Ltd (NASDAQ:ADHD) lost half of its value today after announcing that the …

Read more

Maxim Boosts Price Target for AEterna Zentaris Inc. (USA) (AEZS); Shares Rose 11%

Maxim analyst Jason Kolbert is out with a bullish research report today on AEterna Zentaris …

Read more

Cantor Wary on Alcobra Ltd Following Phase III Trial Failure

Alcobra Ltd (NASDAQ:ADHD) disappointed investors today with the news that its MEASURE trial failed to …

Read more

Canaccord Cheers Mast Therapeutics Inc (MSTX) In Light Of Strategic Merger With Savara

Mast Therapeutics Inc (NYSEMKT:MSTX) and privately held pharmaceutical firm Savara Inc. have announced the intent …

Read more